Product
Placebo matching dupilumab
1 clinical trial
1 indication
Indication
Peanut AllergyClinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)Status: Completed, Estimated PCD: 2020-10-16